# A Single Site, Randomized, Double-blind, Placebo Controlled Trial of NIC5-15 in Subjects With Alzheimer's Disease

> **NCT01928420** · PHASE2 · COMPLETED · sponsor: **Humanetics Corporation** · enrollment: 30 (actual)

## Conditions studied

- Alzheimer's Disease
- Dementia

## Interventions

- **DRUG:** Drug: NIC5-15
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01928420
- **Lead sponsor:** Humanetics Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-04
- **Primary completion:** 2014-06
- **Final completion:** 2014-06
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2016-10-17

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01928420

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01928420, "A Single Site, Randomized, Double-blind, Placebo Controlled Trial of NIC5-15 in Subjects With Alzheimer's Disease". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01928420. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*